Profiel
Bradley J.
Powers is Chief Compliance Officer & General Counsel at Lumos Pharma, Inc. since 2020.
Formerly, Mr. Powers was Principal Executive Officer & General Counsel at NewLink Genetics Corp.
from 2019 to 2020 and General Counsel & Sales Director at KINZE Manufacturing, Inc. from 2013 to 2015.
Education includes undergraduate and graduate degrees from Iowa State University and a graduate degree from Drake University Law School.
Actieve functies van Bradley Powers
| Bedrijven | Functie | Begin |
|---|---|---|
| LUMOS PHARMA, INC. | Compliance Officer | 18-03-2020 |
Eerdere bekende functies van Bradley Powers
| Bedrijven | Functie | Einde |
|---|---|---|
KINZE Manufacturing, Inc.
KINZE Manufacturing, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets planters and grain auger carts | Algemeen Adviseur | 01-08-2015 |
| LUMOS PHARMA, INC. | Algemeen Directeur | 18-03-2020 |
Opleiding van Bradley Powers
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
NewLink Genetics Corp.
NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Iowa State University
Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KINZE Manufacturing, Inc.
KINZE Manufacturing, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets planters and grain auger carts | Producer Manufacturing |
Drake University Law School
Drake University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumos Pharma, Inc.
Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
















